These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14963200)

  • 41. Treatment strategies and outcome of induction-refractory Wegener's granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial.
    Seror R; Pagnoux C; Ruivard M; Landru I; Wahl D; Rivière S; Aussant S; Mahr A; Cohen P; Mouthon L; Guillevin L;
    Ann Rheum Dis; 2010 Dec; 69(12):2125-30. PubMed ID: 20643762
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of leflunomide 10 mg versus 20 mg once daily in patients with active rheumatoid arthritis: multinational double-blind, randomized trial.
    Poór G; Strand V;
    Rheumatology (Oxford); 2004 Jun; 43(6):744-9. PubMed ID: 15026583
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
    Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B
    Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.
    Cartin-Ceba R; Golbin JM; Keogh KA; Peikert T; Sánchez-Menéndez M; Ytterberg SR; Fervenza FC; Specks U
    Arthritis Rheum; 2012 Nov; 64(11):3770-8. PubMed ID: 22730028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Leflunomide: a manageable safety profile.
    van Riel PL; Smolen JS; Emery P; Kalden JR; Dougados M; Strand CV; Breedveld FC
    J Rheumatol Suppl; 2004 Jun; 71():21-4. PubMed ID: 15170904
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of rituximab in limited Wegener's granulomatosis with refractory granulomatous manifestations.
    Seo P; Specks U; Keogh KA
    J Rheumatol; 2008 Oct; 35(10):2017-23. PubMed ID: 18688911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rituximab for treatment-resistant extensive Wegener's granulomatosis--additive effects of a maintenance treatment with leflunomide.
    Henes JC; Fritz J; Koch S; Klein R; Horger M; Risler T; Kanz L; Koetter I
    Clin Rheumatol; 2007 Oct; 26(10):1711-5. PubMed ID: 17502992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.
    Kaltwasser JP; Nash P; Gladman D; Rosen CF; Behrens F; Jones P; Wollenhaupt J; Falk FG; Mease P;
    Arthritis Rheum; 2004 Jun; 50(6):1939-50. PubMed ID: 15188371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wegener's granulomatosis in pregnancy: a novel approach to management.
    Masterson R; Pellicano R; Bleasel K; McMahon LP
    Am J Kidney Dis; 2004 Oct; 44(4):e68-72. PubMed ID: 15384037
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
    Reinhold-Keller E
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1909-10. PubMed ID: 12226791
    [No Abstract]   [Full Text] [Related]  

  • 52. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
    Yocum DE; Furst DE; Bensen WG; Burch FX; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisememandle W; Mekki QA;
    Rheumatology (Oxford); 2004 Aug; 43(8):992-9. PubMed ID: 15014199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis.
    Karanikolas G; Charalambopoulos D; Andrianakos A; Antoniades C; Katsilambros N
    J Rheumatol; 2006 Mar; 33(3):486-9. PubMed ID: 16511917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice.
    Perdriger A; Mariette X; Kuntz JL; Brocq O; Kara-Terki R; Loet XL; Cantagrel A; Pavy S; Deslandre CJ; Debiais F; Combe B;
    J Rheumatol; 2006 May; 33(5):865-9. PubMed ID: 16652418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy of Wegener's granulomatosis. Experiences with conventional and stage-adjusted treatment in 111 patients over 24 years].
    Briedigkeit L; Ulmer M; Rheinhold-Keller E; Göbel U; Natusch R; Gross WL
    Z Gesamte Inn Med; 1993 Apr; 48(4):183-9. PubMed ID: 8488691
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Limited utility of rapamycin in severe, refractory Wegener's granulomatosis.
    Koening CL; Hernández-Rodríguez J; Molloy ES; Clark TM; Hoffman GS
    J Rheumatol; 2009 Jan; 36(1):116-9. PubMed ID: 19012360
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Objective monitoring of activity in Wegener's granulomatosis by measurement of serum C-reactive protein concentration.
    Hind CR; Winearls CG; Lockwood CM; Rees AJ; Pepys MB
    Clin Nephrol; 1984 Jun; 21(6):341-5. PubMed ID: 6467689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R; Stipa E; Del Poeta G; Amadori S; Newland AC; Provan D
    Rheumatology (Oxford); 2006 Nov; 45(11):1432-6. PubMed ID: 16632482
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methotrexate plus leflunomide for the treatment of relapsingWegener's granulomatosis. A retrospective uncontrolled study.
    Bremer JP; Ullrich S; Laudien M; Gross WL; Lamprecht P
    Clin Exp Rheumatol; 2010; 28(1 Suppl 57):67-71. PubMed ID: 20412706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
    Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
    Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.